CytoDyn
Phase 1CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $55M
About
CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).
AntibodiesBiologics
Funding History
2Total raised:$55M
Debt$25MMay 15, 2021
PIPE$30MAug 15, 2020